Validation of the Final Microbicidal Process to Prepare
the
Device for the Next Patient
A. Disinfection
FDA recommends that you validate your
disinfection processes and instructions. FDA
also recommends that you follow the recommendations in
device-specific FDA guidance documents or any relevant FDA-recognized
standards.
B. Sterilization
FDA recommends that you validate as well as provide in your
labeling, sterilization cycle
specifications that are consistent with the conventional parameters presented in Appendix
specifications that are consistent with the conventional parameters presented in Appendix
C. This is to ensure that your device is
compatible with the necessary FDA-cleared
reprocessing equipment, and the reprocessing instructions are technically feasible for implementation by users. For reusable devices that are intended to be used sterile,
labeling should include a sterilization process that you have validated to attain a sterility assurance level (SAL) of 10-6 (or 10-3, as appropriate).
reprocessing equipment, and the reprocessing instructions are technically feasible for implementation by users. For reusable devices that are intended to be used sterile,
labeling should include a sterilization process that you have validated to attain a sterility assurance level (SAL) of 10-6 (or 10-3, as appropriate).
Validation data should be generated in
FDA-cleared sterilizers and with FDA-cleared
sterilization accessories (e.g., biological
indicators, physical/chemical sterilization
process indicators, sterilization wraps).
Alternatively, validation data may be generated in sterilizers that can show
equivalent or better control of key sterilization parameters than FDA-cleared
sterilizers. If you choose this approach, you should address differences that
may exist between the test sterilizer and the FDA-cleared sterilizer.
No comments:
Post a Comment